Clinical course of hypertrophic cardiomyopathy patients implanted with a transvenous or subcutaneous defibrillator

被引:9
|
作者
Francia, Pietro [1 ]
Ziacchi, Matteo [2 ]
Adduci, Carmen [1 ]
Ammendola, Ernesto [3 ]
Pieragnoli, Paolo [4 ]
De Filippo, Paolo [5 ]
Rapacciuolo, Antonio [6 ]
Rella, Valeria [7 ]
Migliore, Federico [8 ]
Viani, Stefano [9 ]
Musumeci, Maria Beatrice [1 ]
Biagini, Elena [2 ]
Lovecchio, Mariolina [10 ]
Baldini, Rossella [1 ]
Falasconi, Giulio [11 ,12 ]
Autore, Camillo [1 ]
Biffi, Mauro [2 ]
Cecchi, Franco [4 ,7 ]
机构
[1] Univ Sapienza, St Andrea Hosp, Dept Clin & Mol Med, Cardiol, Rome, Italy
[2] Univ Bologna, Inst Cardiol, Dept Expt Diagnost & Specialty Med, Policlin S Orsola Malpighi, Bologna, Italy
[3] Univ Campania Luigi Vanvitelli, Monaldi Hosp, Dept Translat Med Sci, Naples, Italy
[4] Univ Florence, Careggi Univ Hosp, Florence, Italy
[5] Papa Giovanni XXIII Hosp, Bergamo, Italy
[6] Univ Naples Federico II, Dept Adv Biomed Sci, Naples, Italy
[7] San Luca Hosp, Ist Auxol Italiano, Dept Cardiovasc Neural & Metab Sci, IRCCS, Milan, Italy
[8] Univ Padua, Dept Cardiac Thorac Vasc Sci & Publ Hlth, Padua, Italy
[9] Univ Hosp Pisa, Cardiothorac & Vasc Dept, Cardiol Div 2, Pisa, Italy
[10] Boston Sci, Milan, Italy
[11] Univ Barcelona, Campus Clin, Barcelona, Spain
[12] IRCCS Humanitas Res Hosp, Milan, Italy
来源
EUROPACE | 2023年 / 25卷 / 09期
关键词
Hypertrophic cardiomyopathy; Implantable cardioverter-defibrillator; Subcutaneous implantable cardioverter-defibrillator; Device-related complications; SUDDEN CARDIAC DEATH; CARDIOVERTER-DEFIBRILLATOR; TASK-FORCE; INAPPROPRIATE SHOCKS; EUROPEAN-SOCIETY; PREVENTION; OUTCOMES; THERAPY; ICD; ASSOCIATION;
D O I
10.1093/europace/euad270
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aims The implantable cardioverter-defibrillator (ICD) is a life-saving therapy in patients with hypertrophic cardiomyopathy (HCM) at risk of sudden cardiac death. Implantable cardioverter-defibrillator complications are of concern. The subcutaneous ICD (S-ICD) does not use transvenous leads and is expected to reduce complications. However, it does not provide bradycardia and anti-tachycardia pacing (ATP). The aim of this study was to compare appropriate and inappropriate ICD interventions, complications, disease-related adverse events and mortality between HCM patients implanted with a S- or transvenous (TV)-ICD.Methods and results Consecutive HCM patients implanted with a S- (n = 216) or TV-ICD (n = 211) were enrolled. Propensity-adjusted cumulative Kaplan-Meier curves and multivariate Cox proportional hazard ratios were used to compare 5-year event-free survival and the risk of events. The S-ICD patients had lower 5-year risk of appropriate (HR: 0.32; 95%CI: 0.15-0.65; P = 0.002) and inappropriate (HR: 0.44; 95%CI: 0.20-0.95; P = 0.038) ICD interventions, driven by a high incidence of ATP therapy in the TV-ICD group. The S- and TV-ICD patients experienced similar 5-year rate of device-related complications, albeit the risk of major lead-related complications was lower in S-ICD patients (HR: 0.17; 95%CI: 0.038-0.79; P = 0.023). The TV- and S-ICD patients displayed similar risk of disease-related complications (HR: 0.64; 95%CI: 0.27-1.52; P = 0.309) and mortality (HR: 0.74; 95%CI: 0.29-1.87; P = 0.521).Conclusion Hypertrophic cardiomyopathy patients implanted with a S-ICD had lower 5-year risk of appropriate and inappropriate ICD therapies as well as of major lead-related complications as compared to those implanted with a TV-ICD. Long-term comparative follow-up studies will clarify whether the lower incidence of major lead-related complications will translate into a morbidity or survival benefit. Graphical Abstract
引用
收藏
页数:9
相关论文
共 50 条
  • [41] Subcutaneous Implantable Cardioverter Defibrillator in Hypertrophic Cardiomyopathy: A Systematic Review and Meta-Analysis
    Oliveira, Vinicius M.
    Oliveira, Izadora C.
    Menezes Junior, Antonio da Silva
    CIRCULATION, 2023, 148
  • [42] Subcutaneous ICD implantation in a patient with hypertrophic cardiomyopathy after transvenous ICD failure: A case report
    Baroni, Matteo
    Cattafi, Giuseppe
    Arupi, Michele
    Paolucci, Marco
    Pelenghi, Stefano
    Lunati, Maurizio
    JOURNAL OF ARRHYTHMIA, 2018, 34 (01) : 81 - 83
  • [43] Prognosis of apical hypertrophic cardiomyopathy in patients with an implantable cardioverter defibrillator
    Nakano, M.
    Kondo, Y.
    Nakano, M.
    Kajiyama, T.
    Ito, R.
    Takahira, H.
    Kitagawa, M.
    Sugawara, M.
    Chiba, T.
    Kobayashi, Y.
    EUROPEAN HEART JOURNAL, 2021, 42 : 627 - 627
  • [44] Implantable cardioverter defibrillator in patients with hypertrophic cardiomyopathy - A nationwide study
    Amin, A.
    Tsangaris, A.
    Arora, A.
    Satya, K.
    EUROPEAN HEART JOURNAL, 2018, 39 : 54 - 55
  • [46] Impact of implantable cardioverter defibrillator therapy in patients with hypertrophic cardiomyopathy
    Dias, L. C.
    Saad, E. B.
    Slater, C.
    Inacio, L. A. O., Jr.
    Santos, G. V.
    Camanho, L. E. M.
    Mourilhe-Rocha, R.
    EUROPEAN JOURNAL OF HEART FAILURE, 2022, 24 : 6 - 6
  • [47] The prevalence of internal cardioverter defibrillator complications in patients with hypertrophic cardiomyopathy
    O'mahony, C.
    Cardona, M.
    Quarta, G.
    Lambiase, P. D.
    Elliott, P.
    EUROPEAN HEART JOURNAL, 2010, 31 : 845 - 846
  • [48] Hypertrophic cardiomyopathy in adult patients. Clinical course and prognostic factors in 119 patients
    Candell-Riera, J
    Romero-Farina, G
    Galve, E
    Armadans, L
    Palet, J
    Castell-Conesa, J
    MEDICINA CLINICA, 2004, 123 (01): : 1 - 4
  • [49] SPONTANEOUS VENTRICULAR TACHYCARDIAS IN ISCHEMIC CARDIOMYOPATHY PATIENTS WITH IMPLANTED DEFIBRILLATOR
    Polymeropoulos, K.
    Ioannidis, P.
    Vosnakidis, A.
    Keklikoglou, E.
    Kaltsas, E.
    Zarifis, J.
    JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2011, 22 : S158 - S158
  • [50] Quality of life, depression, and anxiety in patients with a subcutaneous versus transvenous defibrillator system
    Pedersen, Susanne S.
    Carter, Nathan
    Barr, Craig
    Scholten, Marcoen
    Lambiase, Pier D.
    Boersma, Lucas
    Johansen, Jens Brock
    Theuns, Dominic A. M. J.
    PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2019, 42 (12): : 1541 - 1551